Harmony Biosciences LLC

Plymouth Meeting, PA

UEI
TD8KAL6BNW67
CAGE
88TU1
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
630 W Germantown Pike, Plymouth Meeting, PA 19462, USA
Founded
2017
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $656,081
FY2025 $848,482
FY2024 $1,637,384
FY2023 $27,832

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $656,081

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Bulk - wakix 17.8MG tab 36C26026F0062 Veterans Integrated Service Network 20 (VHA) $635,245
Wakix 17.8 MG 36C24526N0090 Veterans Integrated Service Network 5 (VHA) $10,418
Wakix 17.8 MG 36C24526N0088 Veterans Integrated Service Network 5 (VHA) $10,418
Wakix 17.8 MG 36C24525N0995 Veterans Integrated Service Network 5 (VHA) $10,418
Wakix 17.8 MG 36C24525N0983 Veterans Integrated Service Network 5 (VHA) $10,418

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Harmony Biosciences LLC is a for-profit pharmaceutical company headquartered in Plymouth Meeting, Pennsylvania, that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The company operates as a limited liability corporation and serves as a prime contractor to the federal government, with a registered SAM.gov entity beginning in February 2019. Through its federal contracting activities, Harmony Biosciences primarily supplies specialized pharmaceutical products to support veteran healthcare needs across the U.S. Department of Veterans Affairs healthcare system.

Harmony Biosciences LLC has provided extensive federal contracting services exclusively to the Department of Veterans Affairs through delivery orders placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The company's primary product supplied through these contracts is WAKIX (pitolisant) 17.8 mg tablets, a prescription medication used to treat excessive daytime sleepiness and cataplexy in adult patients with narcolepsy. The delivery orders have ranged significantly in value, from approximately $5,000 to over $700,000 per order, with multiple orders issued to various Veterans Integrated Service Networks (VISN) including VISN 5, VISN 20, and VISN 21, serving VA medical centers and healthcare facilities nationwide. All contract awards have been issued without set-aside designations, indicating they were competitively awarded among qualified vendors. The contracts are firm fixed-price delivery orders, with performance primarily taking place at the company's location in Plymouth Meeting, Pennsylvania, and various VA medical centers. No subcontractors or sub-tier partners have been identified in the contract documentation, and all awards have been directly to Harmony Biosciences as the prime contractor.

Harmony Biosciences LLC currently holds a single-award Blanket Purchase Agreement (BPA) valued at $25,000,000 with the U.S. Department of Veterans Affairs National Acquisition Center, awarded on June 18, 2025, with an ultimate completion date of June 17, 2026. This BPA operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and enables the Veterans Health Administration to issue flexible delivery orders for WAKIX across multiple Veterans Integrated Service Networks throughout the fiscal year without requiring separate competitive solicitations for each requirement. The BPA was awarded without set-aside designations and provides substantial purchasing flexibility for VA medical centers to obtain WAKIX 17.8 mg tablets consistently throughout the performance period. This $25,000,000 BPA represents a significant expansion of the company's prior contracting relationship with the VA, which previously relied on individual delivery orders and a smaller $259,000 multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract. The BPA structure streamlines procurement efficiency and ensures consistent supply availability of this specialized pharmaceutical product for veteran patients requiring treatment for narcolepsy-related symptoms across the entire VA healthcare system.

Quick answers

Is Harmony Biosciences LLC registered in SAM.gov?

Yes. Harmony Biosciences LLC's SAM.gov registration is active through January 14, 2027.

Which contract vehicles does Harmony Biosciences LLC hold?

Harmony Biosciences LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

How much has Harmony Biosciences LLC received in federal contracts?

Federal contracts obligated $848,482 to Harmony Biosciences LLC in fiscal year 2025 and $3,169,778 in fiscal years 2023 through 2027.

How does Harmony Biosciences LLC rank among federal contractors?

Harmony Biosciences LLC ranked #69 in NAICS 325412 and #98 in PSC 6505 in FY2025.

What is Harmony Biosciences LLC's most recent federal award?

Harmony Biosciences LLC's most recent federal contract award is Bulk - wakix 17.8MG tab (36C26026F0062), from Veterans Integrated Service Network 20 (VHA), on December 1, 2025.

On GovTribe

See Harmony Biosciences LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors